EC Number |
Inhibitors |
Structure |
---|
3.2.1.33 | 1,4-diaminobutane |
putrescine, glycogen debranching enzyme, slight inhibition |
|
3.2.1.33 | 1-deoxynojirimycin |
- |
|
3.2.1.33 | 1-deoxynojirimycin |
in primary rat hepatocytes, the inhibition of glycogen breakdown reaches plateau at 100 microM with 25% inhibition and then remains unchanged |
|
3.2.1.33 | 1-S-dimethylarsino-1-thio-beta-D-glucanopyranoside |
DATG, active site-directed irreversible inhibitor, inhibition: mechanism. Inactivation occurs with significant conformational change |
|
3.2.1.33 | 1-S-dimethylarsino-1-thio-beta-D-glucanopyranoside |
DATG, active site-directed irreversible inhibitor, inhibition: mechanism. Inactivation occurs with significant conformational change; glycogen phosphorylase limit dextrin and Bis-Tris protect from inactivation |
|
3.2.1.33 | 2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol |
Bis-Tris, reversible inhibitor |
|
3.2.1.33 | 2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol |
10 mM: 97% inhibition; Bis-Tris, reversible inhibitor |
|
3.2.1.33 | 2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol |
Bis-Tris, reversible inhibitor; noncompetitive with glycogen phosphorylase limit dextrin, competitive with glucose |
|
3.2.1.33 | 2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol |
- |
|
3.2.1.33 | 2-(2-hydroxyethylamino)-2-hydroxymethyl-1,3-propanediol |
hydroxyethyltris |
|